UBS Group’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-35,553
| Closed | -$7.71M | – | 10364 |
|
|
2021
Q1 | $7.71M | Buy |
35,553
+3,532
| +11% | +$664K | ﹤0.01% | 2185 |
|
|
2020
Q4 | $3.7M | Sell |
32,021
-15,565
| -33% | -$1.74M | ﹤0.01% | 2763 |
|
|
2020
Q3 | $4.63M | Sell |
47,586
-26,827
| -36% | -$3.09M | ﹤0.01% | 2276 |
|
|
2020
Q2 | $9.13M | Sell |
74,413
-51,996
| -41% | -$5.9M | ﹤0.01% | 1570 |
|
|
2020
Q1 | $11.1M | Sell |
126,409
-3,051
| -2% | -$323K | 0.01% | 1332 |
|
|
2019
Q4 | $13.5M | Buy |
129,460
+16,283
| +14% | +$1.83M | ﹤0.01% | 1674 |
|
|
2019
Q3 | $13M | Buy |
113,177
+5,439
| +5% | +$826K | 0.01% | 1557 |
|
|
2019
Q2 | $18.6M | Buy |
107,738
+14,679
| +16% | +$2.54M | 0.01% | 1264 |
|
|
2019
Q1 | $15.7M | Buy |
93,059
+6,743
| +8% | +$1M | 0.01% | 1319 |
|
|
2018
Q4 | $8.41M | Sell |
86,316
-17,452
| -17% | -$2.29M | ﹤0.01% | 1707 |
|
|
2018
Q3 | $17.9M | Buy |
103,768
+21,372
| +26% | +$3.08M | 0.01% | 1284 |
|
|
2018
Q2 | $11.5M | Sell |
82,396
-515
| -0.6% | -$73.2K | 0.01% | 1615 |
|
|
2018
Q1 | $9.34M | Buy |
82,911
+35,318
| +74% | +$4.44M | ﹤0.01% | 1753 |
|
|
2017
Q4 | $6.28M | Sell |
47,593
-843
| -2% | -$99.1K | ﹤0.01% | 2133 |
|
|
2017
Q3 | $4.92M | Buy |
48,436
+16,637
| +52% | +$1.78M | ﹤0.01% | 2225 |
|
|
2017
Q2 | $3.19M | Sell |
31,799
-6,270
| -16% | -$675K | ﹤0.01% | 2560 |
|
|
2017
Q1 | $4.6M | Sell |
38,069
-3,026
| -7% | -$371K | ﹤0.01% | 2144 |
|
|
2016
Q4 | $4.59M | Buy |
41,095
+10,710
| +35% | +$1.29M | ﹤0.01% | 2174 |
|
|
2016
Q3 | $4.03M | Buy |
30,385
+17,924
| +144% | +$1.71M | ﹤0.01% | 2215 |
|
|
2016
Q2 | $1.14M | Buy |
12,461
+3,069
| +33% | +$258K | ﹤0.01% | 3271 |
|
|
2016
Q1 | $678K | Buy |
9,392
+93
| +1% | +$5.1K | ﹤0.01% | 3551 |
|
|
2015
Q4 | $645K | Buy |
9,299
+2,431
| +35% | +$198K | ﹤0.01% | 3750 |
|
|
2015
Q3 | $628K | Buy |
6,868
+1,967
| +40% | +$219K | ﹤0.01% | 3711 |
|
|
2015
Q2 | $602K | Sell |
4,901
-485
| -9% | -$55K | ﹤0.01% | 3961 |
|
|
2015
Q1 | $491K | Sell |
5,386
-441
| -8% | -$35.8K | ﹤0.01% | 4167 |
|
|
2014
Q4 | $394K | Buy |
+5,827
| New | +$426K | ﹤0.01% | 4401 |
|
Other funds holding GWPH
UBS Group's GWPH Position: Q2 2021 in Review
UBS Group sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 35,553 shares — an estimated $7.71M sold.
UBS Group first reported a position in GWPH in Q4 2014 and held it in 26 quarters. The position peaked at $18.6M in Q2 2019. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.
- UBS Group reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
- UBS Group sold 35,553 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $7.71M.
- UBS Group first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2014 and held it in 26 quarters.
- UBS Group's GW Pharmaceuticals Plc American Depositary Shares position peaked at $18.6M in Q2 2019.
- 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.
Based on UBS Group's 13F filing for Q2 2021, filed 13 Aug 2021.